Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer
In this cohort study of patients with mCRC, clinical characteristics were associated with different survival outcomes in patients treated with ICI-based therapy, with important clinical implications for patients with MSS tumors who are generally unresponsive to immunotherapy.
Authors
- Marco Matejcic (ORCID: https://orcid.org/0000-0003-3582-0968)
- İbrahim Halil Şahin (ORCID: https://orcid.org/0000-0003-2758-3077)
- Richard D. Kim (ORCID: https://orcid.org/0000-0002-8448-844X)
- Jamie K. Teer (ORCID: https://orcid.org/0000-0003-4513-0282)
- Seth Felder (ORCID: https://orcid.org/0000-0001-6975-8379)
- Stephanie L. Schmit (ORCID: https://orcid.org/0000-0001-5931-1194)
- Timothy A. Chan (ORCID: https://orcid.org/0000-0002-9265-0283)
- Benjamin Daniel Powers (ORCID: https://orcid.org/0000-0003-2679-6302)
- Shahla Bari (ORCID: https://orcid.org/0000-0002-8459-8518)
- Hao Xie (ORCID: https://orcid.org/0000-0002-1328-8985)
Institutions
- University of Maryland, Baltimore (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- University of Pittsburgh (US)
- Moffitt Cancer Center (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Duke Medical Center (US)
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
- Duke Cancer Institute
- Case Western Reserve University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.1186
- Citations
- 8
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 8.36